{
    "code": "02020021",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020021",
    "time": "2020-03-20 03:06:26",
    "許可證字號": "衛署藥輸字第020021號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/07\/29",
    "發證日期": "107\/03\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202002100",
    "中文品名": "培爾吉平注射液１毫克\/毫升",
    "英文品名": "PERDIPINE INJECTION 1MG\/ML",
    "適應症": "適用於當口服治療不可行或不合適時、對高血壓的短期處置。",
    "劑型": "270注射劑",
    "包裝": "2公撮及10公撮安瓿 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "89\/07\/29",
    "主成分略述": "NICARDIPINE HCL",
    "限制項目": "02輸　入",
    "申請商名稱": "1408404100  台灣第一三共股份有限公司",
    "申請商地址": "台北市中山區八德路二段308號7樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0628000  NIPRO PHARMA CORPORATION ISE PLANT",
            "製造廠廠址": "647-240, Ureshinotengeji-cho, Matsusaka-shi, Mie 515-2302, Japan",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2412001410",
            "成分名稱": "NICARDIPINE HCL",
            "含量描述": "1",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "培爾吉平注射液1毫克-毫升標籤(PDI-L1504-02)-104-10-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020021&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "046_代理權移轉_第一三共_1086037001_仿單-109-02-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020021&Seq=010&Type=9"
        },
        {
            "title": "046_代理權移轉_第一三共_1086037001_標籤-109-02-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020021&Seq=005&Type=8"
        },
        {
            "title": "046_代理權移轉_第一三共_1086037001_外盒-109-02-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020021&Seq=004&Type=8"
        }
    ]
}